(Rac)-Sabcomeline

CAS No. 149156-36-5

(Rac)-Sabcomeline( —— )

Catalog No. M36220 CAS No. 149156-36-5

(Rac)-Sabcomeline ((Rac)-SB-202026) is an M1/M4 muscarinic agonist used in the study of neurologic disorders such as schizophrenia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 163 In Stock
5MG 276 In Stock
10MG 394 In Stock
25MG 616 In Stock
50MG 830 In Stock
100MG 1097 In Stock
200MG 1479 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (Rac)-Sabcomeline
  • Note
    Research use only, not for human use.
  • Brief Description
    (Rac)-Sabcomeline ((Rac)-SB-202026) is an M1/M4 muscarinic agonist used in the study of neurologic disorders such as schizophrenia.
  • Description
    (Rac)-Sabcomeline ((Rac)-SB-202026) is an M1/M4 muscarinic agonist used in the study of neurologic disorders such as schizophrenia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    AChR
  • Recptor
    AChR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    149156-36-5
  • Formula Weight
    193.25
  • Molecular Formula
    C10H15N3O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N#CC(=NOC)C1CN2CCC1CC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • ±-Darifenacin

    (±)-Darifenacin ((±)-UK-88525) is a potential inhibitor of p53-MDM2 interaction with anticancer activity for the study of overactive bladder, Alzheimer's disease and Parkinson's disease.

  • VU0467154

    VU0467154 is a positive allosteric modulator of the M4 muscarinic acetylcholine receptor.

  • Xanomeline

    Xanomeline (LY-246708) is a functionally selective M1/M4 activator used in the study of neurological disorders such as schizophrenia and has shown promising treatment in preclinical trials.